Cited 28 time in
Corticosteroid Rotation to Alleviate Dexamethasone-Induced Hiccup: A Case Series at a Single Institution
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kang, Jung Hun | - |
| dc.contributor.author | Hui, David | - |
| dc.contributor.author | Kim, Moon Jin | - |
| dc.contributor.author | Kim, Hoon Gu | - |
| dc.contributor.author | Kang, Myoung Hee | - |
| dc.contributor.author | Lee, Gyeong-Won | - |
| dc.contributor.author | Bruera, Eduardo | - |
| dc.date.accessioned | 2022-12-27T01:54:17Z | - |
| dc.date.available | 2022-12-27T01:54:17Z | - |
| dc.date.issued | 2012-03 | - |
| dc.identifier.issn | 0885-3924 | - |
| dc.identifier.issn | 1873-6513 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/22299 | - |
| dc.description.abstract | Dexamethasone, one of the key medications for the prevention of chemotherapy-induced nausea and vomiting (CINV), may cause hiccups as an adverse effect. In this case series, we present five patients who developed hiccups after receiving dexamethasone for CINV. We successfully switched dexamethasone to an equipotent dosage of either methylprednisolone or prednisolone, which resolved the hiccups while maintaining adequate control of CINV. This was achieved without changing the rest of the antiemetic regimen, chemotherapy doses, or the use of other medications such as baclofen, haloperidol, and metoclopramide for hiccups. Further studies on switching dexamethasone to alternative corticosteroids in patients developing hiccups after administration of dexamethasone are warranted. J Pain Symptom Manage 2012;43:625-630. (C) 2012 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER SCIENCE INC | - |
| dc.title | Corticosteroid Rotation to Alleviate Dexamethasone-Induced Hiccup: A Case Series at a Single Institution | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.jpainsymman.2011.04.011 | - |
| dc.identifier.scopusid | 2-s2.0-84857058941 | - |
| dc.identifier.wosid | 000301125200017 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, v.43, no.3, pp 625 - 630 | - |
| dc.citation.title | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | - |
| dc.citation.volume | 43 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 625 | - |
| dc.citation.endPage | 630 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Health Care Sciences & Services | - |
| dc.relation.journalResearchArea | General & Internal Medicine | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
| dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
| dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
| dc.subject.keywordPlus | CISPLATIN-INDUCED EMESIS | - |
| dc.subject.keywordPlus | DOSE INTRAVENOUS METHYLPREDNISOLONE | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | CHEMOTHERAPY | - |
| dc.subject.keywordPlus | ONDANSETRON | - |
| dc.subject.keywordPlus | COMBINATION | - |
| dc.subject.keywordPlus | CANCER | - |
| dc.subject.keywordPlus | NAUSEA | - |
| dc.subject.keywordPlus | TRIAL | - |
| dc.subject.keywordAuthor | Dexamethasone | - |
| dc.subject.keywordAuthor | hiccup | - |
| dc.subject.keywordAuthor | corticosteroid rotation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
